15 References

Abrams, D. I., et al. “Cannabis in Painful HIV-Associated Sensory Neuropathy: A Randomized Placebo-Controlled Trial.” Neurology, vol. 68, no. 7, Feb. 2007, pp. 515–21. n.neurology.org, doi:10.1212/01.wnl.0000253187.66183.9c.

Abuse, National Institute on Drug. Overdose Death Rates. 9 Aug. 2018, https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates.

Alhamoruni, A., et al. “Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability.” Journal of Pharmacology and Experimental Therapeutics, vol. 335, no. 1, Oct. 2010, pp. 92–102. jpet.aspetjournals.org, doi:10.1124/jpet.110.168237.

Andreae, Michael H., et al. “Inhaled Cannabis for Chronic Neuropathic Pain: An Individual Patient Data Meta-Analysis.” The Journal of Pain : Official Journal of the American Pain Society, vol. 16, no. 12, Dec. 2015, pp. 1221–32. PubMed Central, doi:10.1016/j.jpain.2015.07.009.

Battista, N., Di Tommaso, M., Bari, M., & Maccarrone, M. (2012). The endocannabinoid system: an overview. Frontiers in Behavioral Neuroscience, 6. https://doi.org/10.3389/fnbeh.2012.00009

Blake, Alexia, et al. “A Selective Review of Medical Cannabis in Cancer Pain Management.” Annals of Palliative Medicine, vol. 6, no. Suppl 2, Dec. 2017, pp. S215–22. PubMed, doi:10.21037/apm.2017.08.05.

Bonini, S. A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M., & Mastinu, A. (2018). Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. Journal of Ethnopharmacology, 227, 300–315. https://doi.org/10.1016/j.jep.2018.09.004

Bonn-Miller, Marcel O., et al. “Using Cannabis to Help You Sleep: Heightened Frequency of Medical Cannabis Use among Those with PTSD.” Drug and Alcohol Dependence, vol. 136, Mar. 2014, pp. 162–65. PubMed, doi:10.1016/j.drugalcdep.2013.12.008.

Borgelt, Laura M., et al. “The Pharmacologic and Clinical Effects of Medical Cannabis.” Pharmacotherapy, vol. 33, no. 2, Feb. 2013, pp. 195–209. PubMed, doi:10.1002/phar.1187.

Carod-Artal, F. J. (n.d.). Psychoactive plants in ancient Greece, 11.

Carter, Gregory T., et al. “Re-Branding Cannabis: The next Generation of Chronic Pain Medicine?” Pain Management, vol. 5, no. 1, 2015, pp. 13–21. PubMed, doi:10.2217/pmt.14.49.

Casey, Sherelle L., et al. “Cannabis Constituent Synergy in a Mouse Neuropathic Pain Model.” Pain, vol. 158, no. 12, Dec. 2017, pp. 2452–60. PubMed, doi:10.1097/j.pain.0000000000001051.

Constantinescu, Cris S., et al. “Experimental Autoimmune Encephalomyelitis (EAE) as a Model for Multiple Sclerosis (MS).” British Journal of Pharmacology, vol. 164, no. 4, Oct. 2011, pp. 1079–106. PubMed Central, doi:10.1111/j.1476-5381.2011.01302.x.

Fraguas-Sánchez, A. I., & Torres-Suárez, A. I. (2018). Medical Use of Cannabinoids. Drugs, 78(16), 1665–1703. https://doi.org/10.1007/s40265-018-0996-1

Future, Institute of Medicine (US) Committee on Multiple Sclerosis: Current Status and Strategies for the, et al. Clinical and Biological Features. National Academies Press (US), 2001. www.ncbi.nlm.nih.gov, https://www.ncbi.nlm.nih.gov/books/NBK222386/.

Gugliandolo, Agnese, et al. “In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid.” International Journal of Molecular Sciences, vol. 19, no. 7, July 2018. PubMed Central, doi:10.3390/ijms19071992.

Helena. (2018, September 19). Exploring Trichomes, the Key to the Power of Cannabis. Retrieved December 6, 2018, from https://greencamp.com/exploring-trichomes-the-key-to-the-power-of-cannabis/

High’s and Low’s of Growing Cannabis: Indoor vs. Outdoor – Wikileaf. (n.d.). Retrieved December 6, 2018, from https://www.wikileaf.com/thestash/growing-indoor-vs-outdoor-cannabis/

Hill, A. J., et al. “Cannabidivarin Is Anticonvulsant in Mouse and Rat.” British Journal of Pharmacology, vol. 167, no. 8, Dec. 2012, pp. 1629–42. Wiley Online Library, doi:10.1111/j.1476-5381.2012.02207.x.

Hill, Kevin P., et al. “Cannabis and Pain: A Clinical Review.” Cannabis and Cannabinoid Research, vol. 2, no. 1, 2017, pp. 96–104. PubMed, doi:10.1089/can.2017.0017.

Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., … Pertwee, R. G. (2002). International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors. Pharmacological Reviews, 54(2), 161–202.

Jeong, M., Cho, J., Shin, J.-I., Jeon, Y.-J., Kim, J.-H., Lee, S.-J., … Lee, K. (2014). Hempseed oil induces reactive oxygen species- and C/EBP homologous protein-mediated apoptosis in MH7A human rheumatoid arthritis fibroblast-like synovial cells. Journal of Ethnopharmacology, 154(3), 745–752. https://doi.org/10.1016/j.jep.2014.04.052

Jiang, Hong-En, et al. “A New Insight into Cannabis Sativa (Cannabaceae) Utilization from 2500-Year-Old Yanghai Tombs, Xinjiang, China.” Journal of Ethnopharmacology, vol. 108, no. 3, Dec. 2006, pp. 414–22. ScienceDirect, doi:10.1016/j.jep.2006.05.034.

Kim, Philip S., and Michael A. Fishman. “Cannabis for Pain and Headaches: Primer.” Current Pain and Headache Reports, vol. 21, no. 4, Apr. 2017, p. 19. PubMed, doi:10.1007/s11916-017-0619-7.

Ko, G. D., Bober, S. L., Mindra, S., & Moreau, J. M. (2016). Medical cannabis – The Canadian perspective. Journal of Pain Research, 9, 735–744. https://doi.org/10.2147/JPR.S98182

Krumm, Bryan A. “Cannabis for Posttraumatic Stress Disorder: A Neurobiological Approach to Treatment.” The Nurse Practitioner, vol. 41, no. 1, Jan. 2016, pp. 50–54. PubMed, doi:10.1097/01.NPR.0000434091.34348.3c.

Lowenstein, Charles J., and Elizaveta Padalko. “INOS (NOS2) at a Glance.” Journal of Cell Science, vol. 117, no. 14, June 2004, pp. 2865–67. jcs.biologists.org, doi:10.1242/jcs.01166.

Lu, Y., & Anderson, H. D. (2017). Cannabinoid signaling in health and disease. Canadian Journal of Physiology and Pharmacology, 95(4), 311–327. https://doi.org/10.1139/cjpp-2016-0346

Ma, Qiang. “Role of Nrf2 in Oxidative Stress and Toxicity.” Annual Review of Pharmacology and Toxicology, vol. 53, 2013, pp. 401–26. PubMed Central, doi:10.1146/annurev-pharmtox-011112-140320.

Maida, V., and P. J. Daeninck. “A User’s Guide to Cannabinoid Therapies in Oncology.” Current Oncology, vol. 23, no. 6, Dec. 2016, pp. 398–406. www.current-oncology.com, doi:10.3747/co.23.3487.

Mapping the brain, neuron by neuron. (n.d.). Retrieved December 6, 2018, from https://www.sciencedaily.com/releases/2017/08/170810104956.htm

McIlwain, David R., et al. “Caspase Functions in Cell Death and Disease.” Cold Spring Harbor Perspectives in Biology, vol. 5, no. 4, Apr. 2013, p. a008656. cshperspectives.cshlp.org, doi:10.1101/cshperspect.a008656.

Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual Review of Psychology, 64, 21–47. https://doi.org/10.1146/annurev-psych-113011-143739

Mizrachi Zer-Aviv, Tomer, et al. “Cannabinoids and Post-Traumatic Stress Disorder: Clinical and Preclinical Evidence for Treatment and Prevention.” Behavioural Pharmacology, vol. 27, no. 7, 2016, pp. 561–69. PubMed, doi:10.1097/FBP.0000000000000253.

Phd, P. C., Md. (2011, February 20). A Cannabinoid Pharmacopoeia: The four major phytocannabinoids. Retrieved December 6, 2018, from http://cannabinoidpharmacopoeia.blogspot.com/2011/02/cannabidiol-thc.html

Pisanti, S., & Bifulco, M. (2018). Medical Cannabis: A plurimillennial history of an evergreen. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.27725

Poleszak, Ewa, et al. “Cannabinoids in Depressive Disorders.” Life Sciences, vol. 213, Nov. 2018, pp. 18–24. ScienceDirect, doi:10.1016/j.lfs.2018.09.058.

Procaspase-3-1.Gif (380×357). http://blogs.shu.edu/cancer/files/2016/02/Procaspase-3-1.gif. Accessed 6 Dec. 2018.

Quintanilla, Rodrigo A., et al. “Role of PPARγ in the Differentiation and Function of Neurons.” PPAR Research, vol. 2014, 2014. PubMed Central, doi:10.1155/2014/768594.

Rodríguez-Cueto, Carmen, et al. “Neuroprotective Effects of the Cannabigerol Quinone Derivative VCE-003.2 in SOD1G93A Transgenic Mice, an Experimental Model of Amyotrophic Lateral Sclerosis.” Biochemical Pharmacology, vol. 157, Nov. 2018, pp. 217–26. PubMed, doi:10.1016/j.bcp.2018.07.049.

Rudd, Rose A., et al. “Increases in Drug and Opioid-Involved Overdose Deaths – United States, 2010-2015.” MMWR. Morbidity and Mortality Weekly Report, vol. 65, no. 50–51, Dec. 2016, pp. 1445–52. PubMed, doi:10.15585/mmwr.mm655051e1.

Scherma, Maria, et al. “New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders.” Medicines, vol. 5, no. 4, Dec. 2018, p. 107. www-mdpi-com.myaccess.library.utoronto.ca, doi:10.3390/medicines5040107.

Schoeler, Tabea, and Sagnik Bhattacharyya. “The Effect of Cannabis Use on Memory Function: An Update.” Substance Abuse and Rehabilitation, vol. 4, Jan. 2013, pp. 11–27. PubMed Central, doi:10.2147/SAR.S25869.

Scotter, E. L., Abood, M. E., & Glass, M. (2010). The endocannabinoid system as a target for the treatment of neurodegenerative disease. British Journal of Pharmacology, 160(3), 480–498. https://doi.org/10.1111/j.1476-5381.2010.00735.x

Shrivastava, Amresh, et al. “Cannabis Use and Cognitive Dysfunction.” Indian Journal of Psychiatry, vol. 53, no. 3, 2011, pp. 187–91. PubMed Central, doi:10.4103/0019-5545.86796.

Solymosi, K., & Köfalvi, A. (2017). Cannabis: A Treasure Trove or Pandora’s Box? Mini Reviews in Medicinal Chemistry, 17(13), 1223–1291. https://doi.org/10.2174/1389557516666161004162133

Suryadevara, Uma, et al. “Pros and Cons of Medical Cannabis Use by People with Chronic Brain Disorders.” Current Neuropharmacology, vol. 15, no. 6, 2017, pp. 800–14. PubMed, doi:10.2174/1570159X14666161101095325.

Szczeklik, A. “Analgesics, Allergy and Asthma.” Drugs, vol. 32 Suppl 4, 1986, pp. 148–63. PubMed, doi:10.2165/00003495-198600324-00011.

The Endocannabinoid System. (n.d.). Retrieved December 6, 2018, from https://earthsciencetech.com/the-endocannabinoid-system/

Webb, Charles W., and Sandra M. Webb. “Therapeutic Benefits of Cannabis: A Patient Survey.” Hawai’i Journal of Medicine & Public Health: A Journal of Asia Pacific Medicine & Public Health, vol. 73, no. 4, Apr. 2014, pp. 109–11.

Whiting, Penny F., et al. “Cannabinoids for Medical Use: A Systematic Review and Meta-Analysis.” JAMA, vol. 313, no. 24, June 2015, pp. 2456–73. jamanetwork.com, doi:10.1001/jama.2015.6358.

Wilsey, Barth, Thomas Marcotte, Alexander Tsodikov, et al. “A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain.” The Journal of Pain, vol. 9, no. 6, June 2008, pp. 506–21. ScienceDirect, doi:10.1016/j.jpain.2007.12.010.

Wilsey, Barth, Thomas Marcotte, Reena Deutsch, et al. “Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain.” The Journal of Pain: Official Journal of the American Pain Society, vol. 14, no. 2, Feb. 2013, pp. 136–48. PubMed, doi:10.1016/j.jpain.2012.10.009.

Westphal, Dana, et al. “Molecular Biology of Bax and Bak Activation and Action.” Biochimica et Biophysica Acta (BBA) – Molecular Cell Research, vol. 1813, no. 4, Apr. 2011, pp. 521–31. ScienceDirect, doi:10.1016/j.bbamcr.2010.12.019.

Ye, Jianping. “Regulation of PPARγ Function by TNF-α.” Biochemical and Biophysical Research Communications, vol. 374, no. 3, Sept. 2008, pp. 405–08. ScienceDirect, doi:10.1016/j.bbrc.2008.07.068.